New NHS funding for alternative treatment could prevent knee osteoarthritis

An innovative treatment for repairing damaged knee cartilage using cell transplantation will now be funded by the NHS, following approval from the National Institute for Clinical Excellence (NICE). The Autologous Chondrocyte Implantation treatment, more commonly known as ACI, has been developed and trialled during two decades of groundbreaking research supported by Arthritis Research UK.ACI treatment could be life-changing for the estimated 500 people each year who develop a specific type of cartilage damage, usually following a sports injury in their 20s or 30s, which leads to painfulknee osteoarthritis.Until now the only treatment for this type of knee defect would be total joint replacement, a surgery not recommended for people under the age of 50. By treating the problem at an earlier stage, with less invasive surgery, it's hoped the risk of developing knee osteoarthritis in later life will be prevented or delayed.What does ACI involve?ACI involves the collection of healthy cartilage cells from inside the patient’s knee, which are then grown in lab conditions for several weeks, multiplying at least 20 times. A second operation is then carried out to remove the damaged part of the cartilage and the healthy cells are implanted in its place. The cells anchor themselves to the bone within 24 hours, "growing" new cartilage at the damaged site. A patient can expect to return to normal everyday use of their knee in three months and full activities, including sports, within...
Source: Arthritis Research UK - Category: Rheumatology Source Type: news